Skip to content

Gene-diet Interactions on Body Weight Regulation and Lifestyle Parameters.

Genetic Predisposition and Body Weight Regulation. Evaluation of Target-genes in Overweight and Obese Adults, Under Different Dietary Interventions.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04699448
Acronym
iMPROVE
Enrollment
202
Registered
2021-01-07
Start date
2020-04-13
Completion date
2021-04-14
Last updated
2023-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Weight Changes, Gene-diet Interactions, Health Status, Overweight and Obesity, Quality of Life

Keywords

Gene-diet interactions, Nutritional Intervention, Online Self-assessment Tools, Body Composition, Lifestyle characteristics

Brief summary

Increased body weight leading to the development and the establishment of overweight and obesity, has a growing detrimental effect on overall health status and quality of life. Latest research has been focusing on the direct influence of dietary habits on body weight regulation and its synergistic effect with genetic predisposition. The synergistic effect of genetic makeup and dietary habits constitute a major contributing factor, specifically in its manifestation on parameters of the cardiometabolic profile of individuals with elevated body weight. In this context, the aim of the present study is to investigate the effect of two hypocaloric diets with different macronutrient content (a high-carbohydrate/low-fat and a high-protein one) on the body weight loss of an overweight and/or obese adult, Greek population. Moreover, the study aims to explore gene-diet interactions between obesity and weight loss- related target genes and adherence to the proposed dietary schemes. It will further examine influences of the aforementioned factors on body composition, anthropometric indices, such as waist circumference, biochemical biomarkers related to cardiometabolic control and parameters of lifestyle, such as sleep quality. More specifically, 300 participants will be allocated into two groups, following either the high-carbohydrate/low-fat diet or the high-protein diet, for a duration of 3 months. Volunteers will participate in in-person meetings, at baseline and at three months after the beginning of the intervention. Anthropometric measurements and collection of blood samples will take place in each meeting. Demographic data and data on family and medical history, dietary habits, adherence to the Mediterranean diet, overall health status and physical activity will be collected at baseline. Participants will be provided with nutritional counselling and support both at the beginning and throughout the intervention. Participants will further report their monthly progress by completing online questionnaires (namely concerning their body weight, overall health status, physical activity and sleep quality), via use of an online assessment tool developed by our team. The effect of the intervention will be evaluated using anthropometric indices, body composition markers and biochemical biomarkers of cardiometabolic control, pre- and post- intervention. Gene-diet interactions will be assessed via genotyping of DNA samples and statistical analyses will take place via statistical packages, such as PLINK v.1.9.

Interventions

OTHERNutritional intervention.

Diets designed for body weight loss, based on different macronutrient content.

Sponsors

Harokopio University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women of 18 to 65 years of age. * Body Mass Index of over 25kg/m2 (presence of overweight or obesity)

Exclusion criteria

* Pregnancy or lactation. * Unregulated comorbidities (i.e. type 1 or 2 diabetes, cardiovascular disease, gastrointestinal disorders, mental illness, dietary disorders) * Dietary supplements aiming at body weight loss * Parallel participation in a different research study

Design outcomes

Primary

MeasureTime frameDescription
Body Weight3 monthsChanges in body weight compared to baseline.

Secondary

MeasureTime frameDescription
Body fat percentage3 monthsChanges in body fat percentage compared to baseline.
Waist circumference3 monthsChanges in waist circumference compared to baseline.
Visceral fat3 monthsChanges in visceral fat compared to baseline.
Sleep quality3 monthsChanges in sleep quality characteristics compared to baseline. Assessment will take place via use of validated questionnaire.
Overall health status3 monthsChanges in the overall health status compared to baseline. Assessment will take place via use of validated questionnaire.
Biochemical profile3 monthsChanges in biochemical biomarkers related to metabolic syndrome and cardiovascular disease risk (i.e. total cholesterol, glucose, triglyceride and HDL levels) compared to baseline.

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026